TIME TO WAKE UP KENTUCKY & Time to take ACTION CONGRESS

TIME TO WAKE UP KENTUCKY — 

AND A WAKE UP CALL 

TO OUR NATION

Reminding us WHY Kentucky 

Needed to PASS HB 646

A tragic and alarming case unfolding in Kentucky this past week, has once again exposed the serious dangers surrounding abortion-inducing drugs.

AND why, Kentucky Right to Life strongly supported House Bill 646 during the 2026 Legislative Session.

According to reports, 26-year-old Abdulah Mohmand of Bowling Green has been arrested and charged with attempted fetal homicide after allegedly replacing his pregnant girlfriend’s prescription medication with the abortion-inducing drug misoprostol without her knowledge or consent.

The victim, from Glasgow, Kentucky, reportedly contacted Kentucky State Police on May 25 after becoming concerned for the safety of her unborn child when she discovered her medication had been switched. Following an investigation and search warrant, officers allegedly recovered medication matching the pills found in the victim’s possession.


Perhaps most heartbreaking were statements reportedly made during the investigation that the suspect did not want the pregnancy because of fears involving family repercussions.

This case is horrifying. Yet sadly, it is exactly the type of criminal abuse and exploitation that is occurring in our State that Kentucky Right to Life warned lawmakersabout during the 2026 legislative session and why we worked on the drafting of HB 646 and supported the passage of HB 646 in this Session.

HB 646 Was About 

Accountability & Protection

House Bill 646, “An Act Relating to Pharmaceuticals That Terminate Life,” was introduced to address the growing reality of abortion-inducing drugs being trafficked, distributed, mailed, imported, or used outside proper medical oversight.


The legislation sought to:

• strengthen penalties against unlawful trafficking and distribution of abortion-inducing drugs,

• close dangerous enforcement gaps,

• provide civil remedies for victims harmed by these drugs,

• and protect women and unborn children from coercion, abuse, and criminal misuse.


Throughout session, Kentucky Right to Life repeatedly warned that abortion-inducing drugs create dangerous opportunities for:

• coercion,

• domestic abuse,

• human trafficking,

• hidden chemical abortions,

• and women being harmed without informed medical care or even knowledge.


Sadly, this Kentucky case now demonstrates those warnings were not hypothetical.

And, Another Reason – Why the FDA Must Reinstate Safety Regulations

This tragic case is yet another example of why the FDA must immediately reinstate stronger safety protections and oversight surrounding the abortion drug regimen, including mifepristone.


For years, safety safeguards once required women to:

• receive in-person medical evaluations,

• confirm gestational age and rule out ectopic pregnancy,

• obtain physician oversight,

• and receive follow-up care after taking these powerful drugs.


The previous Administration in D.C. removed those standard of care protections … and surround states aggressivly market death through expanded tele-health distribution, mail-order access, and online trafficking networks. 


The result is increasing danger, abuse, coercion, and criminal misuse. For months we have been appealing and pleading and waiting the current Congress, the current Adminstration and the FDA to take ACTION.


Abortion-inducing drugs are not harmless. They are powerful pharmaceuticals specifically designed to end the life of an unborn child while placing women at risk for hemorrhage, infection, incomplete abortion, emotional trauma, and medical complications — often without direct physician supervision.


Women deserve real healthcare and real protections — not dangerous mail-order abortion schemes with little accountability.

Time to Wake Up Kentucky and 

Wake UP America

How many more cases must occur before lawmakers, federal agencies, and our Nation finally acknowledge the growing dangers tied to abortion-inducing drugs?


This is no longer theoretical.



Women are being placed at risk.

Unborn children are losing their lives.

Powerful abortion drugs are increasingly being trafficked, mailed, secretly administered, and distributed outside proper medical oversight.


Kentucky Right to Life is deeply disappointed that HB 646 was denied a hearing during the 2026 legislative session despite repeated warnings about exactly these types of dangers. 


We call on our Kentucky lawmakers to 

Take Action on Day 1 when they return in January 2027.

Please, make saving Kentucky Girls, Women and Babies a priority in 2027. 

Failure to act has consequences.

AND another reason WHY…

Congress Must Act — Defund Planned Parenthood

As time grows short in Congress, Americans who value life, women’s safety, parental rights, and ethical healthcare must raise their voices now.


Congress has an opportunity and responsibility to stop forcing taxpayers to subsidize the nation’s largest abortion provider.


For decades, Planned Parenthood has received hundreds of millions of taxpayer dollars while continuing to expand abortion access, promote abortion-inducing drugs, and lobby against protections for unborn children and women.


Dear Friends of Life – Now is the time to act.

To Contact your U.S. Senator and Congressman, please dial the U.S. Capitol Switchboard at (202) 224-3121. An operator will ask for your ZIP code and connect you directly to your Representative’s or Senator’s office to share your stance on pending legislation


Contact your U.S. Senators and Members of Congress today and urge them to:

• Defund Planned Parenthood


• restore stronger safeguards on abortion-inducing drugs,

• support protections for women and unborn children,

• and hold accountable those who traffic or misuse abortion drugs.


Kentucky families — and American families —

deserve better.



Because every life is a GIFT.



  • Another tragic reminder

Sobering Reality – Just Across a Bridge from Kentucky

Connect with us!

Facebook  X  Instagram

Leave a Reply

Your email address will not be published. Required fields are marked *